THERAPEUTICSMD INC (TXMD)
US88338N2062 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.57M -96.04% | 69.96M 2,622.18% | 1.302M -98.14% | 9.18M 605.07% | 9.282M 1.11% | 9.486M 2.20% | 9.69M 2.15% | 9.894M 2.11% | 10.098M 2.06% | 10.2M 1.01% | |
| EBITDA YoY % growth | -78.84M 48.97% | 11.85M 115.03% | -7.601M -164.14% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -79.58M 48.84% | 10.66M 113.40% | -8.523M -179.95% | 4.794M 156.25% | 4.998M 4.26% | 2.448M -51.02% | 2.754M 12.50% | 3.06M 11.11% | 3.264M 6.67% | 3.468M 6.25% | |
| Operating Margin | -3,096.50% | 15.24% | -654.61% | 52.22% | 53.85% | 25.81% | 28.42% | 30.93% | 32.32% | 34.00% | |
| EPS YoY % growth | -21.50 35.82% | 11.80 154.88% | N/A -103.28% | 0.36 192.11% | 0.36 | 0.17 -51.43% | 0.19 11.76% | 0.20 5.26% | 0.22 10.00% | 0.23 4.55% |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | -100.25% | -0.02 | % | |
| Q3 2023 Q2Q % growth | -0.13 95.85% | -0.05 | -0.08 | -154.90% |
| Q2 2023 Q2Q % growth | -0.24 -101.94% | -0.07 | -0.17 | -236.13% |
| Q1 2023 Q2Q % growth | -0.37 93.50% | 0.06 | -0.43 | -704.58% |
| Q4 2022 Q2Q % growth | 8.23 264.60% | -1.13 | 9.36 | 826.90% |
| Q3 2022 Q2Q % growth | -3.13 43.09% | -0.58 | -2.55 | -438.36% |
| Q2 2022 Q2Q % growth | 12.39 325.27% | -3.10 | 15.49 | 499.57% |
| Q1 2022 Q2Q % growth | -5.69 -3.45% | -4.08 | -1.61 | -39.46% |
| Q4 2021 Q2Q % growth | -5.00 33.33% | -3.91 | -1.09 | -27.87% |
| Q3 2021 Q2Q % growth | -5.50 8.33% | -5.10 | -0.40 | -7.84% |
| Q2 2021 Q2Q % growth | -5.50 42.11% | -5.61 | 0.11 | 1.96% |
| Q1 2021 Q2Q % growth | -5.50 47.62% | -5.92 | 0.42 | 7.03% |
| Q4 2020 Q2Q % growth | -7.50 21.05% | -5.36 | -2.14 | -40.06% |
| Q3 2020 Q2Q % growth | -6.00 7.69% | -6.97 | 0.97 | 13.92% |
| Q2 2020 Q2Q % growth | -9.50 | -8.76 | -0.74 | -8.48% |
| Q1 2020 Q2Q % growth | -10.50 -31.25% | -9.56 | -0.94 | -9.80% |
| Q4 2019 Q2Q % growth | -9.50 | -9.54 | 0.04 | 0.45% |
| Q3 2019 Q2Q % growth | -6.50 | -9.78 | 3.28 | 33.50% |
| Q2 2019 Q2Q % growth | -9.50 | -8.79 | -0.71 | -8.03% |
| Q1 2019 Q2Q % growth | -8.00 | -8.50 | 0.50 | 5.88% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 547K 1,194.00% | % | ||
| Q2 2024 Q2Q % growth | 234K -46.45% | % | ||
| Q1 2024 Q2Q % growth | 313K -24.76% | % | ||
| Q4 2023 Q2Q % growth | 502K -56.35% | 612K | -110K | -17.97% |
| Q3 2023 Q2Q % growth | -50K -114.29% | 510K | -560K | -109.80% |
| Q2 2023 Q2Q % growth | 437K 24.86% | 510K | -73K | -14.31% |
| Q1 2023 Q2Q % growth | 416K -40.57% | 1.734M | -1.318M | -76.01% |
| Q4 2022 Q2Q % growth | 1.15M 101.75% | 24.276M | -23.126M | -95.26% |
| Q3 2022 Q2Q % growth | 350K -98.62% | 27.336M | -26.986M | -98.72% |
| Q2 2022 Q2Q % growth | 350K -98.48% | 23.664M | -23.314M | -98.52% |
| Q1 2022 Q2Q % growth | 700K -96.48% | 18.314M | -17.614M | -96.18% |
| Q4 2021 Q2Q % growth | -65.7M -390.97% | 29.977M | -95.677M | -319.17% |
| Q3 2021 Q2Q % growth | 25.41M 31.39% | 26.389M | -979K | -3.71% |
| Q2 2021 Q2Q % growth | 23M 114.95% | 21.792M | 1.208M | 5.54% |
| Q1 2021 Q2Q % growth | 19.87M 62.20% | 20.163M | -293K | -1.45% |
| Q4 2020 Q2Q % growth | 22.58M 42.01% | 22.326M | 254K | 1.14% |
| Q3 2020 Q2Q % growth | 19.34M -18.47% | 15.637M | 3.703M | 23.68% |
| Q2 2020 Q2Q % growth | 10.7M 75.99% | 10.584M | 116K | 1.10% |
| Q1 2020 Q2Q % growth | 12.25M 210.13% | 11.525M | 725K | 6.29% |
| Q4 2019 Q2Q % growth | 15.9M | 13.084M | 2.816M | 21.52% |
| Q3 2019 Q2Q % growth | 23.72M | 8.303M | 15.417M | 185.68% |
| Q2 2019 Q2Q % growth | 6.08M | 5.222M | 858K | 16.43% |
| Q1 2019 Q2Q % growth | 3.95M | 6.008M | -2.058M | -34.25% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | 0% | 0% |